Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
01 09 2021
Historique:
received: 02 07 2020
revised: 27 10 2020
pubmed: 22 12 2020
medline: 5 10 2021
entrez: 21 12 2020
Statut: ppublish

Résumé

Only a third of patients with eosinophilic granulomatosis with polyangiitis (EGPA) are ANCA-positive, mainly directed against MPO. ANCA directed against PR3 are rarely found in EGPA. We aimed to examine the significance of PR3-ANCA in EGPA. We set up a retrospective European multicentre cohort including 845 patients. Baseline characteristics and outcomes were analysed and compared according to ANCA status. ANCA status was available for 734 patients: 508 (69.2%) ANCA-negative, 210 (28.6%) MPO-ANCA and 16 (2.2%) PR3-ANCA. At baseline, PR3-ANCA patients, compared with those with MPO-ANCA and ANCA-negative, less frequently had active asthma (69% vs 91% and 93%, P = 0.003, respectively) and peripheral neuropathy (31% vs 71% and 47%, P < 0.0001), more frequently had cutaneous manifestations (63% vs 38% and 34%, P = 0.03) and pulmonary nodules (25% vs 10% and 8%, P = 0.046), and lower median eosinophil count (1450 vs 5400 and 3224/mm3, P < 0.0001). Vasculitis relapse-free survival was shorter for PR3-ANCA (hazard ratio 6.05, P = 0.005) and MPO-ANCA patients (hazard ratio 1.88, P = 0.0002) compared with ANCA-negative patients. PR3-ANCA EGPA patients differ from those with MPO-ANCA and negative ANCA, and share clinical features with granulomatosis with polyangiitis. This suggests that PR3-ANCA EGPA could be a particular form of PR3-ANCA-associated vasculitis.

Identifiants

pubmed: 33347592
pii: 6043197
doi: 10.1093/rheumatology/keaa805
doi:

Substances chimiques

Antibodies, Antineutrophil Cytoplasmic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4355-4360

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Matthias Papo (M)

Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France.

Renato A Sinico (RA)

Department of Medicine and Surgery, Università degli Studi di Milano-Bicocca, Milano/Monza, Italy.

Vítor Teixeira (V)

Department of Medicine, University of Cambridge, Cambridge, UK.
Department of Rheumatology, Centro Hospitalar Universitário do Algarve, Portugal.

Nils Venhoff (N)

Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.

Maria-Letizia Urban (ML)

Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy.

Michele Iudici (M)

Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France.
Rheumatology Unit, Geneva University Hospitals, Geneva, Switzerland.

Juliane Mahrhold (J)

Department of Internal Medicine, Rheumatology and Immunology, Vasculitis-Center Tübingen-Kirchheim, Medius Klinik Kirchheim, University of Tübingen, Kirchheim-Teck, Germany.

Francesco Locatelli (F)

Department of Rheumatology, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Pavia, Italy.

Giulia Cassone (G)

Clinical and Experimental Medicine PhD Program, Azienda USL-IRCCS di Reggio Emilia and Università di Modena and Reggio Emilia, Italy.

Franco Schiavon (F)

Operative Unit of Rheumatology, Department of Medicine DIMED, University of Padova, Padova, Italy.

Benjamin Seeliger (B)

Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.

Thomas Neumann (T)

Department of Rheumatology, Clinic of Internal Medicine II I, Jena University Hospital, Jena, Germany.
Division of Rheumatology, Immunology and Rehabilitation, Kantonsspital St Gallen, St Gallen, Switzerland.

Claus Kroegel (C)

Department of Pneumology and Allergology, Clinic of Internal Medicine I, Jena University Hospital, Jena, Germany.

Matthieu Groh (M)

Service de Médecine Interne, Centre de Référence des Syndromes Hyperéosinophiliques-CEREO, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Suresnes, France.

Chiara Marvisi (C)

Rheumatology Unit Università di Modena and Reggio Emilia, Modena, Italy.

Maxime Samson (M)

Department of Internal Medicine and Clinical Immunology, François-Mitterrand Teaching Hospital, University of Bourgogne-Franche-Comté, Dijon, France.

Thomas Barba (T)

Department of Internal Medicine, Hôpital Edouard Herriot, Lyon, France.

David Jayne (D)

Department of Rheumatology, Centro Hospitalar Universitário do Algarve, Portugal.

Arianna Troilo (A)

Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.

Jens Thiel (J)

Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.

Bernhard Hellmich (B)

Rheumatology Unit, Geneva University Hospitals, Geneva, Switzerland.

Sara Monti (S)

Department of Rheumatology, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Pavia, Italy.

Carlomaurizio Montecucco (C)

Department of Rheumatology, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Pavia, Italy.

Carlo Salvarani (C)

Azienda USL-IRCCS di Reggio Emilia, Università di Modena and Reggio Emilia.

Jean-Emmanuel Kahn (JE)

Service de Médecine Interne, Centre de Référence des Syndromes Hyperéosinophiliques-CEREO, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Suresnes, France.

Bernard Bonnotte (B)

Department of Internal Medicine and Clinical Immunology, François-Mitterrand Teaching Hospital, University of Bourgogne-Franche-Comté, Dijon, France.

Cécile-Audrey Durel (CA)

Department of Internal Medicine, Hôpital Edouard Herriot, Lyon, France.

Xavier Puéchal (X)

Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France.

Luc Mouthon (L)

Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France.

Loïc Guillevin (L)

Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France.

Giacomo Emmi (G)

Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy.

Augusto Vaglio (A)

Nephrology Unit, Meyer Children's Hospital and Department of Biomedical, Experimental and Clinical Sciences, University of Firenze, Italy.

Benjamin Terrier (B)

Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH